Select Publications

Book Chapters

Pett SL; Emery S, 2010, 'Atazanavir', in Grayson ML; Crowe SM; McCarthy JS; Mills J; Mouton JW; Norrby SR; Paterson DL; Pfaller MA (ed.), Kucers' the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs, Hodder Arnold, London, pp. 2830 - 2841

Pett SL; Post JJ, 2009, 'Mycobacterium tuberculosis', in Hoy J; Lewin S; Post JJ; Street A (ed.), HIV Management in Australasia: a guide for clinical care, Australasian Society for HIV Medicine Inc., Darlinghurst, NSW, pp. 149 - 153

Pett SL; Cooper DA, 2008, 'Classification and spectrum', in Mildvan D (ed.), International Atlas of AIDS, 4th ed., Springer, Philadelphia, PA, pp. 77 - 90

Pett SL; Emery S; Cooper DA, 2006, 'Initial treatment of HIV-1 infection. Online access: www.antimicrobe.org', in Singh N; Swindells S; Shafer R (ed.), HIV Clinical Manual, ESun Technologies, LLC, online

Aichelburg A; Pett SL; Cooper DA, 2002, 'AIDS as a World Health Problem', in AIDS as a World Health Problem, MacMillan Publishers, www.els.net, pp. 1 - 6

Aichelburg A; Pett SL; Cooper DA, 2002, 'AIDS: Understanding HIV Transmission', in Encyclopedia of World Sciences, MacMillan Publishers, www.els.net, pp. 1 - 6

Journal articles

Ko S; Dominguez-Dominguez L; Ottaway Z; Campbell L; Fox J; Burns F; Hamzah L; Ustianowski A; Clarke A; Kegg S; Schoeman S; Jones R; Pett SL; Hudson J; Post FA, 2024, 'Cardiovascular disease risk in people of African ancestry with HIV in the United Kingdom.', HIV Med, http://dx.doi.org/10.1111/hiv.13706

McCabe L; Burns JE; Latifoltojar A; Post FA; Fox J; Pool E; Waters A; Santana B; Garvey L; Johnson M; McGuinness I; Chouhan M; Edwards J; Goodman AL; Cooke G; Murphy C; Collaco-Moraes Y; Webb H; Gregory A; Mohamed F; Rauchenberger M; Ryder SD; Sandford C; Baker JV; Angus B; Boesecke C; Orkin C; Punwani S; Clark A; Gilson R; Dunn D; Pett SL; the MAVMET Study group , 2024, 'MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIV.', AIDS, 38, pp. 1513 - 1522, http://dx.doi.org/10.1097/QAD.0000000000003947

Aggarwal NR; Nordwall J; Braun DL; Chung L; Coslet J; Der T; Eriobu N; Ginde AA; Hayanga AJ; Highbarger H; Holodniy M; Horcajada JP; Jain MK; Kim K; Laverdure S; Lundgren J; Natarajan V; Nguyen HH; Pett SL; Phillips A; Poulakou G; Price DA; Robinson P; Rogers AJ; Sandkovsky U; Shaw-Saliba K; Sturek JM; Trautner BW; Waters M; Reilly C; ACTIV-3/TICO Study Group , 2024, 'Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.', Clin Infect Dis, 78, pp. 1490 - 1503, http://dx.doi.org/10.1093/cid/ciad780

Moore AEB; Burns JE; Sally D; Milinkovic A; Krokos G; John J; Rookyard C; Borca A; Pool ERM; Tostevin A; Harman A; Dulnoan DS; Gilson R; Arenas-Pinto A; Cook GJR; Saunders J; Dunn D; Blake GM; Pett SL, 2024, 'Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV.', AIDS, 38, pp. 521 - 529, http://dx.doi.org/10.1097/QAD.0000000000003811

Scott K; Chappell E; Mostafa A; Volokha A; Najmi N; Ebeid F; Posokhova S; Sikandar R; Vasylyev M; Zulfiqar S; Kaminskyi V; Pett S; Malyuta R; Karpus R; Ayman Y; Ahmed RHM; Hamid S; El-Sayed MH; Gibb D; Judd A; Collins IJ, 2024, 'Acceptability of hepatitis C screening and treatment during pregnancy in pregnant women in Egypt, Pakistan, and Ukraine: A cross-sectional survey.', Clin Liver Dis (Hoboken), 23, pp. e0140, http://dx.doi.org/10.1097/CLD.0000000000000140

Hachicha-Maalej N; Collins IJ; Ades AE; Scott K; Judd A; Mostafa A; Chappell E; Hamdy-El-Sayed M; Gibb D; Pett S; Mariné-Barjoan E; Volokha A; Yazdanpanah Y; Deuffic-Burban S, 2024, 'Corrigendum to "Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine" [J Hepatol (2023) 937-946].', J Hepatol, 80, pp. 379, http://dx.doi.org/10.1016/j.jhep.2023.12.013

Arenas-Pinto A; Bakewell N; Milinkovic A; Williams I; Vera J; Post FA; Anderson J; Beynon M; O'Brien A; Doyle N; Gilson R; Pett SL; Winston A; Sabin CA; Pharmacokinetic and clinical Observations in People over fiftY [POPPY]) study , 2024, 'Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohort.', HIV Med, 25, pp. 95 - 106, http://dx.doi.org/10.1111/hiv.13540

Hachicha-Maalej N; Lepers C; Collins IJ; Mostafa A; Ades AE; Judd A; Scott K; Gibb DM; Pett S; Indolfi G; Yazdanpanah Y; El Sayed MH; Deuffic-Burban S, 2024, 'Modelling the potential clinical and economic impact of universal antenatal hepatitis C (HCV) screening and providing treatment for pregnant women with HCV and their infants in Egypt: a cost-effectiveness study', BMJ Public Health, 2, pp. e000517 - e000517, http://dx.doi.org/10.1136/bmjph-2023-000517

Anagnostou N; Archuleta S; Athan E; Barina L; Best E; Bloomfield M; Bostock J; Botheras C; Bowen A; Britton P; Burden H; Campbell A; Carter H; Cheng M; Chew KL; Chong IRLM; Coombs G; Daley P; Daneman N; Davies J; Davis J; Dishon-Benattar Y; Dotel R; Dunlop A; Flack F; Flanagan K; Foo H; Ghanem-Zoubi N; Giulieri S; Goodman A; Grant J; Gregson D; Guy S; Gwee A; Hardy E; Henderson A; Heriot G; Howden B; Hudson F; Johnstone J; Kalimuddin S; de Kretser D; Kwa A; Lee T; Legg A; Lewis R; Llewelyn M; Lumley T; Lye D; MacFadden D; Mahar R; Malhame I; Marks M; Marsh J; Martinello M; Matthews G; McArthur C; McGlothlin A; McKew G; McMullan B; McQuilten Z; Milliken E; Mora J; Morpeth S; Murthy S; Nourse C; O'Sullivan M; Paterson D; Paul M; Petersiel N; Petrella L; Pett S; Price D; Roberts J; Robinson JO; Rogers B; Saville B; Scarborough M; Scheetz M; Scheuerman O; Schwartz K; Smith S; Snelling T; Soares M; Sommerville C; Stewardson A; Stone N; Sud A; Tilley R; Tong S; Turner R; Underwood J; van Hal S; Voss L; Walls G; Webb R; Webb S; Whiteway L; Wilson H; Wuerz T; Yahav D, 2023, 'The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe (vol 75, pg 2027, 2022)', CLINICAL INFECTIOUS DISEASES, http://dx.doi.org/10.1093/cid/ciac730

Flower B; Hung LM; Mccabe L; Ansari MA; Le Ngoc C; Vo Thi T; Vu Thi Kim H; Nguyen Thi Ngoc P; Phuong LT; Quang VM; Dang Trong T; Le Thi T; Nguyen Bao T; Kingsley C; Smith D; Hoglund RM; Tarning J; Kestelyn E; Pett SL; van Doorn R; Van Nuil JI; Turner H; Thwaites GE; Barnes E; Rahman M; Walker AS; Day JN; Chau NVV; Cooke GS, 2023, 'Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study.', Elife, 12, http://dx.doi.org/10.7554/eLife.81801

Grundmann A; Wu C-H; Hardwick M; Baillie JK; Openshaw PJM; Semple MG; Böhning D; Pett S; Michael BD; Thomas RH; Galea I; ISARIC4C investigators , 2023, 'Fewer COVID-19 Neurological Complications with Dexamethasone and Remdesivir.', Ann Neurol, 93, pp. 88 - 102, http://dx.doi.org/10.1002/ana.26536

Hachicha-Maalej N; Collins IJ; Ades AE; Scott K; Judd A; Mostafa A; Chappell E; Hamdy-El-Sayed M; Gibb D; Pett S; Mariné-Barjoan E; Volokha A; Yazdanpanah Y; Deuffic-Burban S, 2023, 'Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine.', J Hepatol, 78, pp. 937 - 946, http://dx.doi.org/10.1016/j.jhep.2022.12.032

Sy A; McCabe L; Hudson E; Ansari AM; Pedergnana V; Lin S-K; Santana S; Fiorino M; Ala A; Stone B; Smith M; Nelson M; Barclay ST; McPherson S; Ryder SD; Collier J; Barnes E; Walker AS; Pett SL; Cooke G; STOP-HCV-1 trial team , 2023, 'Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus.', PLoS One, 18, pp. e0280551, http://dx.doi.org/10.1371/journal.pone.0280551

Rogers AJ; Wentworth D; Phillips A; Shaw-Saliba K; Dewar RL; Aggarwal NR; Babiker AG; Chang W; Dharan NJ; Davey VJ; Higgs ES; Gerry N; Ginde AA; Hayanga JWA; Highbarger H; Highbarger JL; Jain MK; Kan V; Kim K; Lallemand P; Leshnower BG; Lutaakome JK; Matthews G; Mourad A; Mylonakis E; Natarajan V; Padilla ML; Pandit LM; Paredes R; Pett S; Ramachandruni S; Rehman MT; Sherman BT; Files DC; Brown SM; Matthay MA; Thompson BT; Neaton JD; Lane HC; Lundgren JD, 2022, 'The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19', Annals of Internal Medicine, 175, pp. 1401 - 1410, http://dx.doi.org/10.7326/M22-0924

Douin DJ; Siegel L; Grandits G; Phillips A; Aggarwal NR; Baker J; Brown SM; Chang CC; Goodman AL; Grund B; Higgs ES; Hough CL; Murray DD; Paredes R; Parmar M; Pett S; Polizzotto MN; Sandkovsky U; Self WH; Young BE; Babiker AG; Davey VJ; Kan V; Gelijns AC; Matthews G; Thompson BT; Lane HC; Neaton JD; Lundgren JD; Ginde AA; Meintjes GA; Armstrong W; Glidden D; Maldonado Y; Murray BE; Ray SC; Rolla VC; Saloojee H; Tsiatis AA; Volberding PA; Kimmelman J; Hunsberger S, 2022, 'Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery', American Journal of Respiratory and Critical Care Medicine, 206, pp. 730 - 739, http://dx.doi.org/10.1164/rccm.202112-2836OC

Mylonakis E, 2022, 'Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 A Randomized Controlled Trial', Annals of Internal Medicine, 175, pp. 1266 - 1274, http://dx.doi.org/10.7326/M22-1503

Polizzotto M; Nordwall J; Babiker AG; Phillips A; Vock DM; Eriobu N; Khwaghe V; Paredes R; Mateu L; Ramachandruni S; Narang R; Jain MK; Lazarte SM; Baker JV; Frosch AEP; Poulakou G; Syrigos KN; Arnoczy GS; McBride NA; Robinson PA; Sarafian F; Bhagani S; Taha HS; Benfield T; Liu STH; Antoniadou A; Jensen JUS; Kalomenidis I; Susilo A; Hariadi P; Jensen TO; Morales-Rull JL; Helleberg M; Meegada S; Johansen IS; Canario D; Fernández-Cruz E; Metallidis S; Shah A; Sakurai A; Koulouris N; Trotman R; Weintrob AC; Podlekareva D; Hadi U; Lloyd KM; Røge BT; Saito S; Sweerus K; Malin JJ; Lübbert C; Muñoz J; Cummings MJ; Losso MH; Turner D; Shaw-Saliba K; Highbarger H; Lallemand P; Rehman T; Dewar R; Gerry N; Arlinda D; Chang CC; Grund B; Holbrook M; Holley HP; Hudson F; McNay LA; Murray DD; Pett S; Shaughnessy M; Smolskis MC; Touloumi G; Wright M; Doyle MK; Popik S; Hall C; Ramanathan R; Cao H; Mondou E; Willis T; Thakuria JV; Yel L; Higgs E; Kan VL; Lundgren JD; Neaton JD; Lane HC; Amos L; Carlsen A; Carter A; Davis B; Denning E; DuChene A; Engen N; Grandits G; Harrison M; Kaiser P; Meger S; Murray T, 2022, 'Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial', The Lancet, 399, pp. 530 - 540, http://dx.doi.org/10.1016/S0140-6736(22)00101-5

Murray DD; Babiker AG; Baker JV; Barkauskas CE; Brown SM; Chang CC; Davey VJ; Gelijns AC; Ginde AA; Grund B; Higgs E; Hudson F; Kan VL; Lane HC; Murray TA; Paredes R; Parmar MKB; Pett S; Phillips AN; Polizzotto MN; Reilly C; Sandkovsky U; Sharma S; Teitelbaum M; Thompson BT; Young BE; Neaton JD; Lundgren JD, 2022, 'Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)', Clinical Trials, 19, pp. 52 - 61, http://dx.doi.org/10.1177/17407745211049829

Burns JE; Stirrup O; Waters L; Dunn D; Gilson R; Pett SL, 2022, 'No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naïve adults.', HIV Med, 23, pp. 294 - 300, http://dx.doi.org/10.1111/hiv.13186

Grundmann A; Hardwick M; Wu C-H; Semple M; Böhning D; Pett S; Michael B; Thomas R; Galea I, 2022, 'Prevention of neurological complications during COVID-19: a retrospective analysis of the ISARIC4C national cohort', Journal of Neurology, Neurosurgery & Psychiatry, 93, pp. e2.135 - e2.135, http://dx.doi.org/10.1136/jnnp-2022-abn2.22

Murray DD; Babiker AG; Baker J; Barkauskas CE; Brown SM; Chang CC; Davey VJ; Gelijns AC; Ginde AA; Grund B; Higgs E; Hudson F; Kan VL; Lane HC; Murray TA; Paredes R; Parmar MKB; Pett S; Phillips AN; Polizzotto MN; Reilly C; Sandkovsky U; Sharma S; Teitelbaum M; Thompson BT; Young BE; Neaton JD; Lundgren JD, 2021, 'Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)', CLINICAL TRIALS, 19, pp. 52 - 61, http://dx.doi.org/10.1177/17407745211049829

Hung R; Patel N; Fox J; Cosgrove C; Pett SL; Burns F; Ustianowski A; Rosenvinge M; Bhagani S; Dusheiko G; Childs K; Post FA; GEN-AFRICA study group , 2021, 'Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.', AIDS, 35, pp. 1701 - 1704, http://dx.doi.org/10.1097/QAD.0000000000002929

Cooke GS; Pett S; McCabe L; Jones C; Gilson R; Verma S; Ryder SD; Collier JD; Barclay ST; Ala A; Bhagani S; Nelson M; Ch'Ng C; Stone B; Wiselka M; Forton D; McPherson S; Halford R; Nguyen D; Smith D; Ansari A; Dennis E; Hudson F; Barnes EJ; Walker AS, 2021, 'Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C', Wellcome Open Research, 6, pp. 93 - 93, http://dx.doi.org/10.12688/wellcomeopenres.16594.2

Pett SL; Spyer M; Haddow LJ; Nhema R; Benjamin LA; Najjuka G; Bilima S; Daud I; Musoro G; Kitabalwa J; Selemani G; Kandie S; Cornelius KM; Katemba C; Berkley JA; Hassan AS; Kityo C; Hakim J; Heyderman RS; Gibb DM; Walker AS, 2021, 'Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status', AIDS, 35, pp. 585 - 594, http://dx.doi.org/10.1097/QAD.0000000000002781

Butler M; Tamborska A; Wood GK; Ellul M; Thomas RH; Galea I; Pett S; Singh B; Solomon T; Pollak TA; Michael BD; Nicholson TR, 2021, 'Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder.', J Neurol Neurosurg Psychiatry, 92, pp. 1144 - 1151, http://dx.doi.org/10.1136/jnnp-2021-326924

Flower B; McCabe L; Le Ngoc C; Le Manh H; Le Thanh P; Dang Trong T; Vo Thi T; Vu Thi Kim H; Nguyen Tat T; Phan Thi Hong D; Nguyen Thi Chau A; Dinh Thi T; Tran Thi Tuyet N; Tarning J; Kingsley C; Kestelyn E; Pett SL; Thwaites G; Nguyen Van VC; Smith D; Barnes E; Ansari MA; Turner H; Rahman M; Walker AS; Day J; Cooke GS, 2021, 'High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis With 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH Study.', Open Forum Infect Dis, 8, pp. ofab267, http://dx.doi.org/10.1093/ofid/ofab267

Judd A; Collins IJ; Pett S; Gibb DM, 2021, 'Labour pains: eliminating HCV in women and children.', Lancet Gastroenterol Hepatol, 6, pp. 150 - 151, http://dx.doi.org/10.1016/S2468-1253(20)30373-3

Wendt CH; Castro-Pearson S; Proper J; Pett S; Griffin TJ; Kan V; Carbone J; Koulouris N; Reilly C; Neaton JD; INSIGHT FLU003 Plus Study Group , 2021, 'Metabolite profiles associated with disease progression in influenza infection.', PLoS One, 16, pp. e0247493, http://dx.doi.org/10.1371/journal.pone.0247493

Ray STJ; Abdel-Mannan O; Sa M; Fuller C; Wood GK; Pysden K; Yoong M; McCullagh H; Scott D; McMahon M; Thomas N; Taylor M; Illingworth M; McCrea N; Davies V; Whitehouse W; Zuberi S; Guthrie K; Wassmer E; Shah N; Baker MR; Tiwary S; Tan HJ; Varma U; Ram D; Avula S; Enright N; Hassell J; Ross Russell AL; Kumar R; Mulholland RE; Pett S; Galea I; Thomas RH; Lim M; Hacohen Y; Solomon T; Griffiths MJ; Michael BD; Kneen R; CoroNerve study group , 2021, 'Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study.', Lancet Child Adolesc Health, 5, pp. 631 - 641, http://dx.doi.org/10.1016/S2352-4642(21)00193-0

Alagaratnam J; Stöhr W; Toombs J; Heslegrave A; Zetterberg H; Gisslén M; Pett S; Nelson M; Clarke A; Nwokolo N; Johnson MA; Khan M; Hanke T; Kopycinski J; Dorrell L; Fox J; Kinloch S; Underwood J; Pace M; Frater J; Winston A; Fidler S; RIVER trial study group , 2021, 'No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach.', J Virus Erad, 7, pp. 100056, http://dx.doi.org/10.1016/j.jve.2021.100056

Nugent D; Stirrup O; Pett S; Panwar K; Checchi M; Mesher D; Soldan K; Beddows S; Gilson R, 2021, 'Performance of human papillomavirus DNA detection in residual specimens taken for Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification testing in men who have sex with men.', Sex Transm Infect, 97, pp. 541 - 546, http://dx.doi.org/10.1136/sextrans-2020-054702

Ross Russell AL; Hardwick M; Jeyanantham A; White LM; Deb S; Burnside G; Joy HM; Smith CJ; Pollak TA; Nicholson TR; Davies NWS; Manji H; Easton A; Ray S; Zandi MS; Coles JP; Menon DK; Varatharaj A; McCausland B; Ellul MA; Thomas N; Breen G; Keddie S; Lunn MP; Burn JPS; Quattrocchi G; Dixon L; Rice CM; Pengas G; Al-Shahi Salman R; Carson A; Joyce EM; Turner MR; Benjamin LA; Solomon T; Kneen R; Pett S; Thomas RH; Michael BD; Galea I, 2021, 'Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study.', Brain Commun, 3, pp. fcab168, http://dx.doi.org/10.1093/braincomms/fcab168

Cooke GS; Pett S; McCabe L; Jones C; Gilson R; Verma S; Ryder SD; Collier JD; Barclay ST; Ala A; Bhagani S; Nelson M; Ch'Ng C; Stone B; Wiselka M; Forton D; McPherson S; Halford R; Nguyen D; Smith D; Ansari A; Dennis E; Hudson F; Barnes EJ; Walker AS, 2021, 'Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C.', Wellcome Open Res, 6, pp. 93, http://dx.doi.org/10.12688/wellcomeopenres.16594.2

Phillips AN; Bansi-Matharu L; Cambiano V; Ehrenkranz P; Serenata C; Venter F; Pett S; Flexner C; Jahn A; Revill P; Garnett GP, 2021, 'The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis.', Lancet Glob Health, 9, pp. e620 - e627, http://dx.doi.org/10.1016/S2214-109X(21)00025-5

Burns JE; Stöhr W; Kinloch-De Loes S; Fox J; Clarke A; Nelson M; Thornhill J; Babiker A; Frater J; Pett SL; Fidler S, 2021, 'Tolerability of four-drug antiretroviral combination therapy in primary HIV-1 infection.', HIV Med, 22, pp. 770 - 774, http://dx.doi.org/10.1111/hiv.13118

Cooke GS; Pett S; McCabe L; Jones C; Gilson R; Verma S; Ryder SD; Collier JD; Barclay ST; Ala A; Bhagani S; Nelson M; Ch’Ng CL; Stone B; Wiselka M; Forton D; McPherson S; Halford R; Nguyen D; Smith D; Ansari MA; Ainscough H; Dennis E; Hudson F; Barnes EJ; Walker AS, 2021, 'Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT', Efficacy and Mechanism Evaluation, 8, pp. 1 - 90, http://dx.doi.org/10.3310/eme08170

Noor NM; Pett SL; Esmail H; Crook AM; Vale CL; Sydes MR; Parmar MKB, 2020, 'Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings', F1000Research, 9, pp. 1109 - 1109, http://dx.doi.org/10.12688/f1000research.26253.1

McCabe L; White IR; Chau NVV; Barnes E; Pett SL; Cooke GS; Walker AS; SEARCH investigators , 2020, 'The design and statistical aspects of VIETNARMS: a strategic post-licensing trial of multiple oral direct-acting antiviral hepatitis C treatment strategies in Vietnam.', Trials, 21, pp. 413, http://dx.doi.org/10.1186/s13063-020-04350-x

Fidler S; Stöhr W; Pace M; Dorrell L; Lever A; Pett S; Kinloch-de Loes S; Fox J; Clarke A; Nelson M; Thornhill J; Khan M; Fun A; Bandara M; Kelly D; Kopycinski J; Hanke T; Yang H; Bennett R; Johnson M; Howell B; Barnard R; Wu G; Kaye S; Wills M; Babiker A; Frater J; RIVER trial study group , 2020, 'Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial.', Lancet, 395, pp. 888 - 898, http://dx.doi.org/10.1016/S0140-6736(19)32990-3

Burns JE; Stirrup OT; Dunn D; Runcie-Unger I; Milinkovic A; Candfield S; Lukha H; Severn A; Waters L; Edwards S; Gilson R; Pett SL, 2020, 'No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV', AIDS, 34, pp. 109 - 114, http://dx.doi.org/10.1097/QAD.0000000000002379

Noor NM; Pett SL; Esmail H; Crook AM; Vale CL; Sydes MR; Parmar MKB, 2020, 'Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings.', F1000Res, 9, pp. 1109, http://dx.doi.org/10.12688/f1000research.26253.2

Varatharaj A; Pollak TA; Nicholson TR; Coles JP; Benjamin LA; Carson A; Thomas RH; Michael BD; study authors , 2020, 'Characterising neuropsychiatric disorders in patients with COVID-19 - Authors' reply.', Lancet Psychiatry, 7, pp. 934 - 935, http://dx.doi.org/10.1016/S2215-0366(20)30420-X

Ellul M; Varatharaj A; Nicholson TR; Pollak TA; Thomas N; Easton A; Zandi MS; Manji H; Solomon T; Carson A; Turner MR; Kneen R; Galea I; Pett S; Thomas RH; Michael BD; CoroNerve Steering Committee , 2020, 'Defining causality in COVID-19 and neurological disorders.', J Neurol Neurosurg Psychiatry, 91, pp. 811 - 812, http://dx.doi.org/10.1136/jnnp-2020-323667

Varatharaj A; Thomas N; Ellul MA; Davies NWS; Pollak TA; Tenorio EL; Sultan M; Easton A; Breen G; Zandi M; Coles JP; Manji H; Al-Shahi Salman R; Menon DK; Nicholson TR; Benjamin LA; Carson A; Smith C; Turner MR; Solomon T; Kneen R; Pett SL; Galea I; Thomas RH; Michael BD; CoroNerve Study Group , 2020, 'Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.', Lancet Psychiatry, 7, pp. 875 - 882, http://dx.doi.org/10.1016/S2215-0366(20)30287-X


Back to profile page